CONTENT HUB

Latest news

Here, you will find announcements, advancements in synthetic DNA technology, and insights into our contributions to the fields of vaccines, gene therapy, cell therapy and gene editing

Blanka Awtani 23/11/2021 Blanka Awtani 23/11/2021

Joint development agreement with Leucid Biofor novel CAR T-cell production methods

23 NOV 2021

Press Release: Joint development agreement between 4basebio and Leucid Bio

Blanka Awtani 28/09/2021 Blanka Awtani 28/09/2021

Development of GMP manufacturing capacity

28 SEP 2021

Press Release: Commenced the development of its pilot clean room project for the purpose of manufacturing GMP standard DNA

Blanka Awtani 30/06/2021 Blanka Awtani 30/06/2021

Result of Annual General Meeting

30 JUN 2021

Press Release: 4basebio announces that all of the resolutions proposed at its Annual General Meeting held earlier today were duly passed

Blanka Awtani 22/06/2021 Blanka Awtani 22/06/2021

Patent application - Application filed for protected linearised synthetic DNA

22 JUN 2021

Press Release: Application filed for protected linearised synthetic DNA

Blanka Awtani 04/06/2021 Blanka Awtani 04/06/2021

Notice of Annual General Meeting

04 JUN 2021

Press Release: 4basebio confirms that the Annual Report and Accounts for the year ended 30 December 2020

Blanka Awtani 27/04/2021 Blanka Awtani 27/04/2021

Evaluation licence for muscular dystrophy vector

27 APR 2021

Press Release: 4basebio has signed research collaboration and evaluation license agreements with Royal Holloway University of London